Amentum Faces Growth Slump As Government Cuts Spending, Analyst Expects Merger To Boost Margins
1. Goldman Sachs rated AMTM as Neutral with a $21 price forecast. 2. AMTM has lower valuation but significant revenue and backlog. 3. The merger with Jacobs may enhance margins and cash flow. 4. Sector headwinds could hinder revenue growth and margins. 5. EBITDA projections for FY25 and FY26 exceed consensus estimates.